Northwestern Mutual Wealth Management
XLRN

Northwestern Mutual Wealth Management’s Acceleron Pharma XLRN Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-72
Closed -$1K – 2523
2016
Q4 		$1K Buy
+72
New +$2.28K ﹤0.01% 2287
2016
Q3 		– Sell
-171
Closed -$6K – 1713
2016
Q2 		$6K Buy
171
+116
+211% +$3.77K ﹤0.01% 1553
2016
Q1 		$1K Buy
+55
New +$1.6K ﹤0.01% 2064

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Northwestern Mutual Wealth Management's XLRN Position: Q1 2017 in Review

Northwestern Mutual Wealth Management sold out of Acceleron Pharma (XLRN) in Q1 2017, closing a stake of 72 shares — an estimated $1K sold.

Northwestern Mutual Wealth Management first reported a position in XLRN in Q1 2016 and held it in 3 quarters. The position peaked at $6K in Q2 2016. 136 funds tracked by Wall St. Rank hold XLRN as of Q1 2017.

  • Northwestern Mutual Wealth Management reported no remaining Acceleron Pharma position as of Q1 2017 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 72 Acceleron Pharma shares in Q1 2017, an estimated $1K.
  • Northwestern Mutual Wealth Management first reported a position in Acceleron Pharma in Q1 2016 and held it in 3 quarters.
  • Northwestern Mutual Wealth Management's Acceleron Pharma position peaked at $6K in Q2 2016.
  • 136 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2017.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.